Author

Mark K. Polar

Observed names: M. Polar, Mark K Polar

Institutions: University of Miami, Sylvester Comprehensive Cancer Center

Observed institutions: University of Miami, Virginia Commonwealth University, University of Virginia Health System, University of Virginia Medical Center, Sylvester Comprehensive Cancer Center, University of Virginia, Virginia Commonwealth University Medical Center

OpenAlex ID: A5074033827

Transition State Analysis of the Coupling of Drug Transport to ATP Hydrolysis by P-glycoprotein

2003 · Marwan K. Al-Shawi, Mark K. Polar, et al. · Journal of Biological Chemistry · 165

Improved Energy Coupling of Human P-glycoprotein by the Glycine 185 to Valine Mutation

2004 · Hiroshi Omote, Robert A. Figler, et al. · Biochemistry · 39

Effect of the vitamin D3 analog ILX 23-7553 on apoptosis and sensitivity to fractionated radiation in breast tumor cells and normal human fibroblasts

2003 · Mark K. Polar, Chris Gennings, et al. · Cancer Chemotherapy and Pharmacology · 39

Conformation of the γ Subunit at the γ−ε−c Interface in the Complete Escherichia coli F1-ATPase Complex by Site-Directed Spin Labeling

2001 · Scott H. Andrews, Yelena B. Peskova, et al. · Biochemistry · 18

PET / CT in the Staging and Treatment Response Assessment of Patients With Extranodal Marginal Zone Lymphoma

2025 · Juan Pablo Alderuccio, Russ A. Kuker, et al. · American Journal of Hematology · 10

PET/CT Enables Appropriate Staging in Extranodal Marginal Zone Lymphoma

2023 · Juan Pablo Alderuccio, Michele D. Stanchina, et al. · Blood · 2

Deep Learning–Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial

2025 · Russ A. Kuker, Juan P. Alderuccio, et al. · JCO Clinical Cancer Informatics · 1

Epcoritamab with R-CHOP Overcomes Poor Risk Features of High Total Metabolic Tumor Volume in High-Risk Large B-Cell Lymphoma

2024 · Juan Pablo Alderuccio, Russ Kuker, et al. · Blood · 1

Association of Body Composition Factors and Toxicity in Patients with Advanced Stage Hodgkin Lymphoma Receiving BV-AVD

2024 · Michele D. Stanchina, Russ Kuker, et al. · Blood · 1

Staging Fdg‐avidity in Extranodal Marginal Zone Lymphoma (emzl) by Disease Location

2023 · J. P. Alderuccio, E. Edelman Saul, et al. · Hematological Oncology · 1

Impact of body composition on toxicity and response in patients with advanced-stage Hodgkin lymphoma treated with BV-AVD

2026 · Michele D. Stanchina, Russ A. Kuker, et al. · Blood Neoplasia

Works count: 11

Citation count: 277

H-index: 5

I10-index: 5